BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679
829 results:

  • 1. [Neurofibromatosis type 1 associated with pheochromocytoma: a case report with a brief review of the literature].
    Lugovskaya AY; Britvin TA; Gurevich LE; Rog IS; Nefedova LN; Ilovayskaya IA
    Probl Endokrinol (Mosk); 2023 Sep; 70(2):53-64. PubMed ID: 38796761
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison of two region-of-interest placement methods for histogram analysis of apparent diffusion coefficient maps for glioma grading.
    Hieu ND; Hung ND; Hung ND; Hien MM; Anh DV; Dung LT
    Clin Ter; 2024; 175(3):128-136. PubMed ID: 38767069
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. PDZK1 is correlated with DCE-MRI perfusion parameters in high-grade glioma.
    Zhang Y; Wang F; Huang Y
    Clinics (Sao Paulo); 2024; 79():100367. PubMed ID: 38692010
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Exploring fetal brain tumor glioblastoma symptom verification with self organizing maps and vulnerability data analysis.
    Natarajan SK; S J; Mathivanan SK; Rajadurai H; M B BAM; Shah MA
    Sci Rep; 2024 Apr; 14(1):8738. PubMed ID: 38627421
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
    Jost J; Völker K; Brandt R; Stummer W; Urbschat S; Ketter R; Wiewrodt D; Wiewrodt R;
    J Neurooncol; 2024 May; 168(1):35-45. PubMed ID: 38561565
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Preoperative 11 C-Methionine PET-MRI in Pediatric Infratentorial tumors.
    Beuriat PA; Flaus A; Portefaix A; Szathmari A; Janier M; Hermier M; Lorthois-Ninou S; Scheiber C; Isal S; Costes N; Merida I; Lancelot S; Vasiljevic A; Leblond P; Faure Conter C; Saunier C; Kassai B; Vinchon M; Di Rocco F; Mottolese C
    Clin Nucl Med; 2024 May; 49(5):381-386. PubMed ID: 38498623
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of [
    Wagatsuma K; Ikemoto K; Inaji M; Kamitaka Y; Hara S; Tamura K; Miwa K; Tsuzura K; Tsuruki T; Miyaji N; Ishibashi K; Ishii K
    Ann Nucl Med; 2024 May; 38(5):400-407. PubMed ID: 38466549
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparison of clinical efficacy and safety between robotic-assisted and laparoscopic adrenalectomy for pheochromocytoma: a systematic review and meta-analysis.
    Wang L; Zeng W; Wu Y; Gong Z
    J Robot Surg; 2024 Mar; 18(1):115. PubMed ID: 38466492
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Protoporphyrin IX in serum of high-grade glioma patients: A novel target for disease monitoring via liquid biopsy.
    Walke A; Krone C; Stummer W; König S; Suero Molina E
    Sci Rep; 2024 Feb; 14(1):4297. PubMed ID: 38383693
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. 68 Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results.
    Waheed A; Singh B; Watts A; Kaur H; Singh H; Dhingra K; Ahuja C; Madan R; Singh A; Radotra BD
    Clin Nucl Med; 2024 Apr; 49(4):e141-e148. PubMed ID: 38350065
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Gallium-68 labeled somatostatin receptor antagonist PET/CT in over 500 patients with neuroendocrine neoplasms: experience from a single center in China.
    Liu M; Cheng Y; Bai C; Zhao H; Jia R; Chen J; Zhu W; Huo L
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2002-2011. PubMed ID: 38337073
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Updates on the genetics of multiple endocrine neoplasia.
    Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
    Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [
    Trautwein NF; Schwenck J; Seitz C; Seith F; Calderón E; von Beschwitz S; Singer S; Reischl G; Handgretinger R; Schäfer J; Lang P; Pichler BJ; Schulte JH; la Fougère C; Dittmann H
    Theranostics; 2024; 14(3):1212-1223. PubMed ID: 38323317
    [No Abstract]    [Full Text] [Related]  

  • 14. Incidental Prostate-Specific Membrane Antigen-Avid Vestibular Schwannoma Detected on 68 Ga-Prostate-Specific Membrane Antigen PET/CT.
    Chen J; Bui P; Bui C; Mansberg R
    Clin Nucl Med; 2024 Mar; 49(3):234-236. PubMed ID: 38271251
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4
    Kovacsovics-Bankowski M; Sweere JM; Healy CP; Sigal N; Cheng LC; Chronister WD; Evans SA; Marsiglio J; Gibson B; Swami U; Erickson-Wayman A; McPherson JP; Derose YS; Eliason AL; Medina CO; Srinivasan R; Spitzer MH; Nguyen N; Hyngstrom J; Hu-Lieskovan S
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38233101
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. PSMA PET/MR is a New Imaging Option for Identifying Glioma Recurrence and Predicting Prognosis.
    Xiong M; Chen Z; Zhou C; Yang X; Hu W; Jiang Y; Zheng R; Fan W; Mou Y; Lin X
    Recent Pat Anticancer Drug Discov; 2024; 19(3):383-395. PubMed ID: 38214322
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
    Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
    Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prediction of
    Mileva M; Marin G; Levillain H; Artigas C; Van Bogaert C; Marin C; Danieli R; Deleporte A; Picchia S; Stathopoulos K; Jungels C; Vanderlinden B; Paesmans M; Ameye L; Critchi G; Taraji-Schiltz L; Velghe C; Wimana Z; Bali M; Hendlisz A; Flamen P; Karfis I
    J Nucl Med; 2024 Feb; 65(2):236-244. PubMed ID: 38164576
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multiparametric Analysis Combining DSC-MR Perfusion and [18F]FET-PET is Superior to a Single Parameter Approach for Differentiation of Progressive Glioma from Radiation Necrosis.
    Panholzer J; Malsiner-Walli G; Grün B; Kalev O; Sonnberger M; Pichler R
    Clin Neuroradiol; 2024 Jun; 34(2):351-360. PubMed ID: 38157019
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Gastric Schwannoma Demonstrated on 18 F FDG PET/CT With Pathological Correlation.
    Chen J; Bui C; Loh H; Mansberg R
    Clin Nucl Med; 2024 Feb; 49(2):166-168. PubMed ID: 38108854
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 42.